Compare LEXX & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | VS |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 7.9M |
| IPO Year | 2011 | 2017 |
| Metric | LEXX | VS |
|---|---|---|
| Price | $3.09 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 82.6K | 12.5K |
| Earning Date | 07-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.97 |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $2,183,415.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 52.05 | ★ 3711.30 |
| 52 Week Low | $0.35 | $0.75 |
| 52 Week High | $14.37 | $2.47 |
| Indicator | LEXX | VS |
|---|---|---|
| Relative Strength Index (RSI) | 35.47 | 40.85 |
| Support Level | $0.57 | $1.01 |
| Resistance Level | $12.89 | $1.18 |
| Average True Range (ATR) | 0.51 | 0.06 |
| MACD | -0.12 | 0.00 |
| Stochastic Oscillator | 25.92 | 19.13 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Versus Systems Inc operates within the technology sector, focusing on engagement-enhancing solutions through its proprietary prizing and promotions platform. This technology enables developers and content creators across streaming, live events, broadcast, gaming, and other media to integrate real-world prizes into their experiences, fostering greater consumer interaction and providing a compelling opportunity for brand partners and advertisers. The company operates in Canada and the USA.